Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study

Carcinogenesis

Volumn 23, Issue 10, 2002, Pages 1641-1646

  Perera, Frederica P ^a   Mooney, LaVerne A ^a   Stampfer, Meir ^b   Phillips, David H ^c   Bell, Douglas A ^d   Rundle, Andrew ^a   Cho, Stan ^a   Tsai, Wei Yann ^a   Ma, Jing ^b   Blackwood, Anne ^e   Tang, Deliang ^a  

^a Columbia University ^*  (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC COMPOUND; BIOLOGICAL MARKER; CARCINOGEN; DNA; GLUTATHIONE TRANSFERASE; ISOLEUCINE; NUCLEASE; PHOSPHORUS 32; POLYCYCLIC AROMATIC HYDROCARBON; TOBACCO SMOKE; VALINE;

AGE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DETOXIFICATION; DIAGNOSTIC VALUE; DNA ADDUCT; DNA DAMAGE; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FOLLOW UP; GENE AMPLIFICATION; GENOTYPE; HUMAN; ISOTOPE LABELING; LEUKOCYTE; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS;

EID: 0036799080     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/23.10.1641     Document Type: Article

References (61)

1. ACS (American Cancer Society) (2002) Cancer Facts and Figures. American Cancer Society, Atlanta, GA.
2. Surgeon General (1986) The Health Consequences of Involuntary Smoking. A report of the Surgeon General. Office of Smoking and Health, Rockville, MD.
3. National Research Council National Academy of Sciences (1986) National Academy Press, Washington, DC.
4. Hecht,S. (1999) Tobacco smoke carcinogens and lung cancer. J. Natl Cancer Inst., 91, 1194-210.
5. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans. vol 32. Polynuclear aromatic compounds. Part I. Chemical, environmental and experimental data. Eds. Expert Group. IARC, Lyon, pp. 1-453.
6. ICF Clement, in collaboration with U.S. Environmental Protection Agency (1990) Toxicological Profile for B(a)P. Oak Ridge National Laboratory, Oak Ridge, TN.
7. Phillips,D. and Castegnaro,M. (1999) Standardization and validation of DNA adduct postlabelling methods: report of interlaboratory trials and production of recommended protocols. Mutagenesis, 14, 301-315.
8. Miller,E.C. and Miller,J.A. (1981) Mechanisms of chemical carcinogenesis. Cancer, 47, 1055-1064.
9. Kriek,E., Rojas,M., Alexandrov,K. and Bartsch,H. (1998) Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. Mutat. Res., 400, 215-231.
10. Mollerup,S., Ryberg,D., Hewer,A., Phillips,D.H. and Haugen,A. (1999) Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res., 59, 3317-3320.
11. Denissenko,M., Pao,A., Tang,M.S. and Pfiefer,G. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science, 274, 430-432.
12. Tang,D., Santella,R.M., Blackwood,A., Young,T.L., MayerJ., Jaretzki,A., Grantham,S., Tsai,W.Y. and Perera,F.P. (1995) A molecular epidemiological case-control study of lung cancer. Cancer Epidemiol. Biomarkers Prev., 4, 341-346.
13. Wiencke,J.K., Thurston,S.W., Kelsey,K.T., Varkonyi,A., Wain,J.C., Mark,E.J. and Christiani,D.C. (1999) Early age at smoking initiation and tobacco carcinogen DNA damage in the lung. J. Natl Cancer Inst., 91, 614-619.
14. Godschalk,R.W., Moonen,E.J., Schilderman,Y.A., Broekmans,W.M., Kleinjans,J.C. and Van Schooten,F.J. (2000) Exposure-route-dependent DNA adduct formation by polycyclic aromatic hydrocarbons. Carcinogenesis, 21, 87-92.
15. Perera,F.P. and Weinstein,I.B. (1982) Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. J. Chron. Dis., 35, 581-600.
16. Wiencke,J., Varkonyi,A., Semey,K., Levay,G., Wain,J., Mark,E., Kelsey,K. and Christiani,D. (1995) Detection of benzene-related DNA adducts in human tissues and evidence of co-activation with polyaromatic hydrocarbons (PAHs). Proc. Am. Assoc. Cancer Res., 36, 135.
17. Bartsch,H., Rojas,M., Alexandrov,K. and Risch,A. (1998) Impact of adduct determination on the assessment of cancer susceptibility. Recent Results Cancer Res., 154, 86-96.
18. Kriek,E., van Schooten,F.J., Hillebrand,M.J.X., van Leeuwen,F.E., den Engelse,L., de Looff,A.J.A. and Dijkmans,A.P.G. (1993) DNA adducts as a measure of lung cancer risk in human exposed to polycyclic aromatic hydrocarbons. Environ. Health Perspect., 99, 71-75.
19. Vineis,P. and Perera,F. (2000) DNA adducts as markers of exposure to carcinogens and risk of cancer. Int. J. Cancer, 88, 325-328.
20. Helzlsouer,K., Selmin,O., Huang,H., Strickland,P., Hoffman,S., Alberg,A., Watson,M., Comstock,G. and Bell,D. (1998) Association between glutathione S-transferase M1, P1 and T1 genetic polymorphisms and development of breast cancer. J. Natl Cancer Inst., 90, 512-518.
21. Hayes,J.D. and Pulford,D.J. (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol., 30, 445-600.
22. Hu,X., Ji,X., Srivastava,S.K., Xia,H., Awashti,S., Nanduri B., Awastshi,Y.C., Zimniak,P. and Singh,S. (1997) Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. Arch. Biochem. Biophys., 345, 32-38.
23. Robertson,I.G.C., Guthenberg,C., Mannervik,B. and Jernstrom,B. (1986) Differences in stereoselectivity and catalytic efficiency of three human glutathione transferases in the conjugation of glutathione with 7B, 8a-dihydroxy-9a, 10a-oxy-7,8,9, 10-tetrahydrobenzo(a)pyrene. Cancer Res., 46, 2220-2224.
24. Salama,S.A., Abdel-Rahman,S.Z., Sierra-Torres,C.H., Hamada,F.A. and Au,WW. (1999) Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity. Pharmacogenetics, 9, 735-743.
25. Hayes,J.D. and Strange,R.C. (2000) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology, 61, 154-166.
26. Watson,M.A., Stewart,R.K., Smith,G.B.J., Massey,T. and Bell,D. (1998) Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis, 19, 275-280.
27. Bell,D.A., Taylor,J.A., Paulson,D.F., Robertson,C.N., Mohler,J.L. and Lucier,G.W. (1993) Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl Cancer Inst., 85, 1159-1164.
28. van Lieshout,E.M. and Peters,W.H. (1998) Age and gender dependent levels of glutathione and glutathione S-transferases in human lymphocytes. Carcinogenesis, 19, 1873-1875.
29. Zimniak,R, Nanduri,B., Pikula,S., Bandorowicz-Pikula,J., Singhal,S.S., Srivastava,S.K., Awasthi,S. and Awasthi,Y.C. (1994) Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur. J. Biochem., 224, 893-899.
30. Hu,X., Xia,H., Srivastava,S.K., Herzog,C., Awasthi,Y.C., Ji,X., Zimniak,P. and Singh,S.V. (1997b) Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem. Biophys. Res. Commun., 238, 397-402.
31. Sundberg,K., Johansson,A., Stenberg,G., Widersten,M., Seidel,A., Mannervik,B. and Jernstrom,B. (1998) Differences in the catalytic efficiences of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis, 19, 433-436.
32. Sundberg,K., Seidel,A., Mannervik,B. and Jernstrom,B. (1998) Detoxication of carcinogenic fjord-region diol epoxides of polycyclic aromatic hydrocarbons by glutathione transferase P1-1 variants and glutathione. FEBS Lett., 438, 206-210.
33. Rebbeck,T.R. (1997) Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomarkers Prev., 6, 733-743.
34. McWilliams,J.E., Sanderson,B.J.S., Harris,E..L., Richert-Boe,K.E. and Henner,W.D. (1995) Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 4, 589-594.
35. Ryberg,D., Skaug,V., Hewer,A., Phillips,D., Harries,L., Wolf,C., Ogreid,D., Ulvik,A., Vu,P. and Haugen,A. (1997) Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis, 18, 1285-1289.
36. Miller,D.P., Xu,L., Fan,R., Su,L., Wain,J., Lynch,T.J. and Christiani,D.C. (2001) Combinations of the variant genotypes of GSTP1, GTSM1 and p53 are associated with an increased lung cancer risk. AACR Proceedings, New Orleans, LA.
37. Pavanello,S. and Clonfero,E. (2000) Biological indicators of genotoxic risk and metabolic polymorphisms. (Review.) Murat. Res., 463, 285-308.
38. Hennekens,C.H., Buring,J.E., Manson,J.E., Stampfer,M., Rosner,B., Cook,N.R., Belanger,C., LaMotte,F., Gaziano,J.M., Ridker,P.M., Willett,W. and Peto,R. (1996) Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. New Engl. J. Med., 334, 1145-1149.
39. Tang,D., Phillips,D.H., Stampfer,M., Mooney,L.A., Hsu,Y., Cho,S., Tsai,W., Ma,J., Cole,K.J., Shé,M.N. and Perera,F.P. (2001) Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Res., 61, 6708-6712.
40. Phillips,D.H., Schoket,B., Hewer,A., Bailey,E., Kostic,S. and Vincze,I. (1990) Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int. J. Cancer 46, 569-575.
41. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures. Carcinogenesis, 9, 1687-1693.
42. Phillips,D.H. and Shé,M.N. (1993) Smoking-related DNA adducts in human cervical biopsies. IARC Scientific Publications No. 124, IARC, Lyon, pp. 327-330.
43. Kelsey,J.L., Thompson,W.D. and Evans,A.S. (1986) Methods in Observational Epidemiology. Oxford University Press, New York.
44. Tang,D., Cho,S., Rundle,A., Chen,S. and Perera,F.P. (2001) PAH-DNA adducts and XRCC1 in breast cancer case-control study. AACR Proceedings, 3203, pp. 596.
45. Miller,E. and Miller,J. (1981) Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer, 47, 2327-2345.
46. Poirier,M.C., Santella,R.M. and Weston,A. (2000) Carcinogen macromolecular adducts and their measurement. Carcinogenesis, 21, 353-359.
47. Rothman,N., Stewart,W. and Schulte,P. (1995) Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories. Cancer Epidemiol. Biomarkers Prev., 4, 301-311.
48. Perera,F.P. (1987) Molecular cancer epidemiology: A new tool in cancer prevention. J. Natl. Cancer Inst., 78, 887-898.
49. Bartsch,H. and Hietanen,E. (1996) The role of individual susceptibility in cancer burden related to environmental exposure. Environ. Health Perspect., 104, 569-577.
50. Spitz,M.R. and Bondy,M.L. (1993) Genetic susceptibility to cancer. Cancer 72, 1991-1995.
51. Khoury,M.J. Genetics Working Group. (1996) From genes to public health: the applications of genetic technology in disease prevention. Am. J. Public Health, 86, 1717-1722.
52. To-Figueras,J., Gene,M., Gomez-Catalan,J., Pique,E., Borrego,N., Carrasco,J.L., Ramon,J. and Corbella,J. (1999) Genetic polymorphism of glutathione S-transferase P1 gene and lung cancer risk. Cancer Causes Control, 10, 65-70.
53. Butkiewicz,D., Gryzbowska,E., Phillips,D.H., Hemminki,K. and Chorazy,M. (2000) Polymorphisms of the GSTP1 and GSTM1 genes and PAH-DNA adducts in human mononuclear white blood cells. Environ. Mol. Mutagen, 35, 99-105.
54. Bartsch,H., Rojas,M., Nair,U. and Alexandrov,K. (1999) Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers and coke oven workers. Cancer Detect. Prev., 23, 445-453.
55. Rojas,M., Cascorbi,I., Alexandrov,K., Kriek,E.A.G., Mayer,L., Kopp-Schneider,A., Roots,I. and Bartsch,H. (2000) Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Carcinogenesis, 21, 35-41.
56. Soni,M., Madurantakan,M. and Krishnaswamy,K. (1998) Glutathione S-transferase Mu (GST Mu) deficiency and DNA adducts in lymphocytes of smokers. Toxicology, 126, 155-162.
57. Rothman,N., Shields,P., Poirier,M.C., Harrington,A.M., Ford,D.P. and Strickland,P.T. (1995) The impact of glutathione S-transferase M1 and cytochrome P450 1A1 genotypes on white blood cell polycyclic aromatic hydrocarbon-DNA adduct levels in humans. Mol. Carcinog., 14, 63-68.
58. Whyatt,R.M., Perera,F.P., Jedrychowski,W, Santella,R.M., Garte,S. and Bell,D.A. (2000) Association between polycyclic aromatic hydrocarbon-DNA adduct levels in maternal and newborn white blood cells and glutathione S-transferase P1 and CYP1A1 polymorphisms. Cancer Epidemiol. Biomarkers Prev., 9, 207-212.
59. Qian,G., Ross,R., Yu,M., Yuan,J., Gao,Y., Henderson,B., Wogan,G. and Groopman,J. (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol. Biomarkers Prev., 3, 3-10.
60. Wang,L., Hatch,M., Chen,C., Levin,B., You,S., Lu,S., Wu,M., Wu,W., Wang,L., Wang,Q., Huang,G., Yang,P., Lee,H. and Santella,R. (1996) Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int. J. Cancer 67, 620-625.
61. Yu,M.W., Lien,J.R, Chiu,Y.H., Santella,R.M., Liaw,Y.F. and Chen,C.J. (1997) Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. J. Hepatol., 27, 320-330.